Track the 에스케이바이오팜 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 에스케이바이오팜 has recorded 33 insider filings. Market capitalisation: €6,922.9bn. The latest transaction was reported on 1 April 2026 (Sale). Among the most active insiders: 조형래. Every trade is accessible without an account.
33
Insider Decl.
0
Thresholds
·
4 ops.
Buy Volume
·
2 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 에스케이바이오팜 Buy (bullish), based on 12 analysts. Average price target: ₩136,917.
9Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 5,283 of 26,220 companies
66.7
score / 100
Value
40
Quality
94
FCF yld2.3%
Earn yld4.2%
EV/EBITDA36.3x
ROE44%
Gross mgn94%
Net mgn38%
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
